BoneSupport’s key product, Cerament™ Spine Support, has received EU approval for the treatment of vertebral fractures in patients suffering from osteoporosis.

The company may now expand its operations from the US and into the major European markets.

Vertebral compression fractures are a worldwide problem. In the European Union they account for 8 % of hospitals’ total osteoporatic fractures costs, at a yearly expense of 377 EURm. The Cerament™ Spine Support treatment is quick, easy and safe to perform.

Read more


 
News type
 
 

Latest PE Voice

Radiocrafts CEO Peder Martin Evjen on how to work with private equity owners.
 
 

Calendar

2010-10-19 in Oslo

VentureLab Investment Forum

2010-09-24 in Stockholm

The Argentum Symposium 2010

2010-09-23 in Stockholm

The Argentum Private Equity Conference

2010-09-08 in Zurich

European Energy Venture Fair
 
Copyright Argentum 2009